推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Research and Treatment 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   IF范围: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
Springer Nature特刊征稿
已发表SCI?是时候来Springer出书了!

按研究方向查看:


Cancer Research and Treatment期刊基本信息Hello,您是该期刊的第62525位访客


基本信息 登录收藏
期刊名字Cancer Research and TreatmentCancer Research and Treatment

CANCER RES TREAT
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.6
60人评分
我要评分

声誉
7.3

影响力
5.6

速度
9.2

期刊ISSN1598-2998
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN2005-9256
2025-2026最新IF
(数据来源于网友提供)
注册登录后,查看IF
实时影响因子 截止2026年5月06日:4.16
2025-2026自引率2.4%点击查看自引率趋势图
五年IF
(数据来源于网友提供)
4.299数据由网友[小鸟4639]收集提供
h-index 28
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
7.701.4621.354
学科分区排名百分位
大类:Medicine
小类:Oncology
Q177 / 428
大类:Medicine
小类:Cancer Research
Q267 / 233

期刊简介
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.
期刊官方网站http://e-crt.org/
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
 
期刊投稿网址http://journal.cancer.or.kr/submission/Login.html
该期刊中国学者近期发文 - NewElevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis
Author: Zheng, Yuqian; Zhou, Shaolong; Tao, Yiran; Shi, Zimin; Li, Xiang; Fu, Xudong; Ma, Jian; Hu, Weihua; Liang, Wulong; Wang, Xinjun
Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. -. DOI: 10.4143/crt.2024.933


Adjuvant Chemotherapy in Breast Cancer after Neoadjuvant Therapy: Essential or Optional?
Author: Zhang, Di; Yang, Luo; Zheng, Yuan; Zhou, Qi
Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. 208-220. DOI: 10.4143/crt.2024.1254


The Role of Circulating Tumor Cell as a Promising Biomarker in the Evaluation of Pulmonary Nodules: A Prospective Study
Author: Wang, Shijie; Xu, Changdan; Xu, Xiaohong; Shao, Weipeng; Wang, Guohui; Yang, Xiongtao; Gao, Liwei; Teng, Feng; Sun, Hongliang; Zhao, Yue; Feng, Hongxiang; Zhu, Guangying
Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. 128-140. DOI: 10.4143/crt.2024.841


Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: A European and East Asian Populations-Based Mendelian Randomization Analysis
Author: Chen, Jiansheng; Zeng, Aiming; Yu, Yunzhe; Sun, Sida; Liao, Liqun; Huang, Siwei; Yang, Zhongshan; Zhou, Junfeng; Wu, Weijie
Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. 242-251. DOI: 10.4143/crt.2024.875


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Research and Treatment的语言要求,还能让Cancer Research and Treatment编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Research and Treatment编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇)
提交文稿
是否OA开放访问Yes
通讯方式RM 1824, GWANGHWAMUN OFFICIA, 92 SAEMUNAN-RO, JONGNO-GU, SEOUL, SOUTH KOREA, 110-999
出版商Korean Cancer Association
涉及的研究方向ONCOLOGY-
出版国家或地区SOUTH KOREA
出版语言English
出版周期
出版年份0
年文章数 107点击查看年文章数趋势图
Gold OA文章占比99.43%
研究类文章占比:
文章 ÷(文章 + 综述)
97.20%
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 1区3区4区
ONCOLOGY
肿瘤学
2区2区3区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
ONCOLOGY
肿瘤学
1区2区3区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区2区
ONCOLOGY
肿瘤学
3区1区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1598-2998%5BISSN%5D
平均审稿速度网友分享经验:
>12周,或约稿
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Research and Treatment顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇)
提交文稿
期刊常用信息链接
同领域相关期刊 Cancer Research and Treatment期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Research and Treatment期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Research and Treatment上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE898637
    JOURNAL OF ETHNOPHARMACOLOGY803130
    Frontiers in Immunology746613
    BIOMEDICINE & PHARMACOTHERAPY726009
    BIOMATERIALS715670
    Frontiers in Pharmacology715117
    PHYTOMEDICINE643857
    Frontiers in Oncology619580
    Biomedical Signal Processing and Control600489
    IEEE Journal of Biomedical and Health Informatics597345
  •  

    Cancer Research and Treatment Cancer Research and Treatment
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Elevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis

    Author: Zheng, Yuqian; Zhou, Shaolong; Tao, Yiran; Shi, Zimin; Li, Xiang; Fu, Xudong; Ma, Jian; Hu, Weihua; Liang, Wulong; Wang, Xinjun
    Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. -. DOI: 10.4143/crt.2024.933
        PubMed      DOI
    2.Adjuvant Chemotherapy in Breast Cancer after Neoadjuvant Therapy: Essential or Optional?

    Author: Zhang, Di; Yang, Luo; Zheng, Yuan; Zhou, Qi
    Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. 208-220. DOI: 10.4143/crt.2024.1254
        PubMed      DOI
    3.The Role of Circulating Tumor Cell as a Promising Biomarker in the Evaluation of Pulmonary Nodules: A Prospective Study

    Author: Wang, Shijie; Xu, Changdan; Xu, Xiaohong; Shao, Weipeng; Wang, Guohui; Yang, Xiongtao; Gao, Liwei; Teng, Feng; Sun, Hongliang; Zhao, Yue; Feng, Hongxiang; Zhu, Guangying
    Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. 128-140. DOI: 10.4143/crt.2024.841
        PubMed      DOI
    4.Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: A European and East Asian Populations-Based Mendelian Randomization Analysis

    Author: Chen, Jiansheng; Zeng, Aiming; Yu, Yunzhe; Sun, Sida; Liao, Liqun; Huang, Siwei; Yang, Zhongshan; Zhou, Junfeng; Wu, Weijie
    Journal: CANCER RESEARCH AND TREATMENT. 2026; Vol. 58, Issue 1, pp. 242-251. DOI: 10.4143/crt.2024.875
        PubMed      DOI
    5.Synergistic Activation of LEPR and ADRB2 Induced by Leptin Enhances Reactive Oxygen Specie Generation in Triple-Negative Breast Cancer Cells

    Author: Liu, Chang; Yu, Jing; Du, Yongjun; Xie, Yu; Song, Xiaofei; Yan, Yan; Wang, Yue; Qin, Junfang
    Journal: CANCER RESEARCH AND TREATMENT. 2025; Vol. 57, Issue 2, pp. 457-477. DOI: 10.4143/crt.2024.368
        PubMed      DOI
    6.Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study

    Author: Hao, Chunfang; Wang, Xu; Shi, Yehui; Tong, Zhongsheng; Li, Shufen; Liu, Xiaodong; Zhang, Lan; Zhang, Jie; Meng, Wenjing; Zhang, Li
    Journal: CANCER RESEARCH AND TREATMENT. 2025; Vol. 57, Issue 2, pp. 434-442. DOI: 10.4143/crt.2024.340
        PubMed      DOI
    7.The Oncogenic Role of TNFRSF12A in Colorectal Cancer and Pan-Cancer Bioinformatics Analysis

    Author: Wang, Chuyue; Zhao, Yingying; Chen, You; Shi, Ying; Yang, Zhiying; Wu, Weili; Ma, Rui; Wang, Bo; Sun, Yifeng; Yuan, Ping
    Journal: CANCER RESEARCH AND TREATMENT. 2025; Vol. 57, Issue 1, pp. 212-228. DOI: 10.4143/crt.2024.408
        PubMed      DOI
    8.Integrated Transcriptomic Landscape and Deep Learning Based Survival Prediction in Uterine Sarcomas

    Author: Song, Yaolin; Li, Guangqi; Zhang, Zhenqi; Liu, Yinbo; Jia, Huiqing; Zhang, Chao; Wang, Jigang; Hu, Yanjiao; Hao, Fengyun; Liu, Xianglan; Xie, Yunxia; Ma, Ding; Li, Ganghua; Tai, Zaixian; Xing, Xiaoming
    Journal: CANCER RESEARCH AND TREATMENT. 2025; Vol. 57, Issue 1, pp. 250-266. DOI: 10.4143/crt.2024.343
        PubMed      DOI
    9.A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2-Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response

    Author: Shao, Qing; Zhang, Ningning; Pan, Xianjun; Zhou, Wenqi; Wang, Yali; Chen, Xiaoliang; Wu, Jing; Zeng, Xiaohua
    Journal: CANCER RESEARCH AND TREATMENT. 2025; Vol. 57, Issue 1, pp. 126-139. DOI: 10.4143/crt.2023.1251
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    Foundations and Trends in Computer Graphics and Vision032.80
    PROGRESS IN REACTION KINETICS AND MECHANISM2321.60
    Journal of Obesity & Metabolic Syndrome014.40
    Advanced Sensor and Energy Materials03.70
    Business & Information Systems Engineering018.50
    Business & Information Systems Engineering018.50
    Battery Energy015.10
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM425.50
    PROGRESS IN PHOTOVOLTAICS11518.50
    Degenerative Neurological and Neuromuscular Disease00.00
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共148


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室